In this study, RMND5B was found to be low risk in the risk model, and Cell RT-qPCR validation revealed that its levels were suppressed in multiple pancreatic cancer cells, implying that it may exist as a tumor suppressor gene in pancreatic cancer, which contradicts the findings from other studies. The gene discussed is RMND5B; the disease is pancreatic neoplasm.